0000000000173762

AUTHOR

Henrique Lopes

0000-0002-7586-401x

showing 2 related works from this author

ASPHER Statement

2021

Submitted by Agostinho Macau (arm@ucp.pt) on 2021-09-14T08:06:58Z No. of bitstreams: 1 ijph_66_1604361.pdf: 553290 bytes, checksum: 213f7a1eaedc390557eeae306bfc3262 (MD5) Made available in DSpace on 2021-09-14T08:06:58Z (GMT). No. of bitstreams: 1 ijph_66_1604361.pdf: 553290 bytes, checksum: 213f7a1eaedc390557eeae306bfc3262 (MD5) Previous issue date: 2021-08-23 info:eu-repo/semantics/publishedVersion

2019-20 coronavirus outbreakmedicine.medical_specialtyHealth (social science)Coronavirus disease 2019 (COVID-19)pandemic ; winter planning ; COVID-19 ; Public Health ; third waveStatement (logic)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Library sciencePolitical sciencePandemicmedicineHumansThird waveWinter planningPandemicPublic healthPublic Health ArchivePublic Health Environmental and Occupational HealthCOVID-19Déjà vuCommentarySeasonsPublic HealthPublic aspects of medicineRA1-1270Third waveInternational Journal of Public Health
researchProduct

Let's End HepC: modelling public health epidemiological policies applied to Hepatitis C in Spain

2022

Background: The WHO has defined international targets toward the elimination of hepatitis C by 2030. Most countries cannot be on track to achieve this goal unless many challenges are surpassed. The Let's End HepC (LEHC) tool aims to contribute to the control of hepatitis C. The innovation of this tool combines the modelling of public health policies (PHP) focused on hepatitis C with epidemiological modelling of the disease, obtaining a unique result that allows to forecast the impact of policy outcomes. The model was applied to several countries, including Spain.Methods: To address the stated objective, we applied the “Adaptive Conjoint Analysis” for PHP decision-making and Markov Chains in…

Public healthCONJOINT-ANALYSISPublic Health Environmental and Occupational HealthHCV INFECTIONHIVHealth literacyPublic PolicyHepacivirusVIRUS-INFECTIONAntiviral AgentsHepatitis CDISEASEModellingPREVALENCESpainPEOPLEHumansPublic aspects of medicineRA1-1270BURDENPublic health policiesOriginal Research
researchProduct